✅ #EMPEROR-Pooled trial: a pooled analysis of two randomised trials has demonstrated the beneficial effects of empagliflozin in patients with heart failure with a reduced and preserved ejection fraction

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫

✅ #EMPEROR-Preserved trial: empagliflozin reduces the risk of a composite of #cardiovascular death or hospitalisation for #heartfailure in patients with #HFpEF with or without #diabetes

📖#ESCCongress

✨Join Us✨

📲 http://t.me/Irathero 💫